Publicación:
Capacidades operativas de las definiciones de caso de COVID-19, para detectar pacientes diagnosticados por RT-PCR.

dc.contributor.authorTeherán, Aníbal A.spa
dc.contributor.authorCamero Ramos, Gabrielspa
dc.contributor.authorPrado de la Guardia, Ronaldspa
dc.contributor.authorSanabria, Cindyspa
dc.contributor.authorMartínez, Víctor M.spa
dc.contributor.authorPombo, Luis Miguelspa
dc.contributor.authorOspina, María del Pilarspa
dc.contributor.authorMora, Lyst E.spa
dc.date.accessioned2020-08-24T17:19:24Z
dc.date.accessioned2025-08-05T14:25:18Z
dc.date.available2020-08-24T17:19:24Z
dc.date.available2025-08-05T14:25:18Z
dc.date.issued2020-08-24
dc.description.abstractObjetivo. Las definiciones operativas de caso (D.O.C.) para el nuevo coronavirus (COVID-19) se construyeron para identificar personas potencialmente infectadas (PPI), en esta investigación medimos las capacidades operativas de sus componentes para discriminar infectados con COVID-19. Metodología. Con un diseño de corte transversal, utilizando datos contenidos en las fichas de notificación obligatorias y registros médicos de PPI de COVID-19 entre marzo-mayo/2020, atendidos por Cruz Roja IPS en Bogotá, se describieron las características sociodemográficas y clínicas, y se determinaron las capacidades operativas de las D.O.C. y sus componentes para discriminar pacientes diagnosticados con COVID-19 por RT-PCR. Resultados. Se identificaron 2174 PPI de COVID-19, la prevalencia de infectados fue 14.7%, edad mediana 36 años, 57.7% mujeres, la mayoría presentó contacto estrecho, entre 12.7-21.1% de infectados eran trabajadores de la salud y 35.2% asintomáticos portadores. Los infectados presentaron con mayor frecuencia fiebre (32.8%; p: <0.001), y en general, 50-60% presentaron síntomas respiratorios. La sensibilidad de las manifestaciones clínicas fue menor al 50%. Los componentes de las D.O.C. más sensibles y específicos para discriminar infectados con COVID-19, respectivamente, fueron el antecedente de contacto estrecho y de viajes a áreas de transmisión local comunitaria en los últimos 14 días. Discusión. La baja sensibilidad de las manifestaciones clínicas para discriminar pacientes infectados con COVID-19, induce a actualizar las D.O.C. para mejorar la identificación de PPI. Adicionalmente, las medidas para prevenir la propagación en escenarios de atención de urgencias deben optimizarse y contemplar un tamizaje rutinario en salas No COVID.spa
dc.description.abstractObjetive. The operational case definitions (OCD) for the new coronavirus (COVID-19) were constructed to identify potentially infected persons (PIP), in this investigation we measured the operational capabilities of its components to discriminate COVID-19 persons infected. Methodology. A cross-sectional design was performed using data contained in the mandatory notification records and PPI medical records of COVID-19 between March-May / 2020, attended by the IPS Red Cross in Bogota, the sociodemographic and clinical characteristics were described, and determined the operational capabilities of OCDs and its components to discriminate patients diagnosed with COVID-19 by RT-PCR. Results. 2174 PIPs of COVID-19 were identified, the prevalence of those infected was 14.7%, median age 36 years, 57.7% women, the majority presented close contact, between 12.7-21.1% of those infected were health workers and 35.2% were asymptomatic carriers. Those infected more frequently presented fever (32.8%; p: <0.001), and in general, 50-60% presented respiratory symptoms. The sensitivity of the clinical manifestations was less than 50%. The components of the OCD most sensitive and specific to discriminate infected with COVID-19, respectively, were the history of close contact and trips to areas of local community transmission in the last 14 days. Discussion. The low sensitivity of clinical manifestations to discriminate patients infected with COVID-19, leads to update the OCD to improve PIP identification. Additionally, measures to prevent the spread in emergency care settings should be optimized and include a routine screening in Non-COVID rooms.eng
dc.format.mimetypeapplication/pdfspa
dc.identifier.doi10.26752/cuarzo.v26.n1.500
dc.identifier.eissn2500-7181
dc.identifier.issn0121-2133
dc.identifier.urihttps://repositorio.juanncorpas.edu.co/handle/001/420
dc.identifier.urlhttps://doi.org/10.26752/cuarzo.v26.n1.500
dc.language.isospaspa
dc.publisherFundación Universitaria Juan N. Corpasspa
dc.relation.bitstreamhttps://revistas.juanncorpas.edu.co/index.php/cuarzo/article/download/500/438
dc.relation.citationendpage21
dc.relation.citationissue1spa
dc.relation.citationstartpage16
dc.relation.citationvolume26spa
dc.relation.ispartofjournalRevista Cuarzospa
dc.relation.referencesLaiton K, Villabona CJ, Usme JA, Franco C, Alvarez DA, Villabona LS, et al. Genomic epidemiology of SARS-CoV-2 in Colombia. medRxiv 2020.06.26.20135715; doi: https://doi.org/10.1101/2020.06.26.20135715.spa
dc.relation.referencesTeheran AA, Camero G, Prado R, Hernandez C, Herrera G, Pombo LM, et al. Epidemiological characterization of asymptomatic carriers of COVID-19 in Colombia. medRxiv 2020.06.18.20134734; doi: https://doi.org/10.1101/2020.06.18.20134734.spa
dc.relation.referencesWorld Health Organization. (‎2020)‎. Novel Coronavirus (‎‎‎‎2019-nCoV)‎‎‎‎: situation report, 1. World Health Organization. https://apps.who.int/iris/handle/10665/330760spa
dc.relation.referencesRamirez JD, Munoz M, Hernandez C, Florez C, Gomez S, Rico A, et al. Genetic diversity among SARS-CoV2 strains in South America may impact performance of Molecular detection. medRxiv 2020.06.18.20134759; doi: https://doi.org/10.1101/2020.06.18.20134759.spa
dc.relation.referencesAmariles P, Granados J, Ceballos M, Montoya CJ. COVID-19 in Colombia endpoints. Are we different, like Europe? Res Social Adm Pharm. 2020 Mar 31. doi: http://10.1016/j.sapharm.2020.03.013.spa
dc.relation.referencesKorber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W; on behalf of the Sheffield COVID-19 Genomics Group. Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell (2020), doi: https://doi.org/10.1016/j.cell.2020.06.043.spa
dc.relation.referencesGrant MC, Geoghegan L, Arbyn M, Mohammed Z, McGuinness L, Clarke EL, et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries. PLoS One. 2020 Jun 23;15(6):e0234765. doi: 10.1371/journal.pone.0234765.spa
dc.relation.referencesGao Z, Xu Y, Sun C, Wang X, Guo Y, Qiu S, et al. A Systematic Review of Asymptomatic Infections with COVID-19. J Microbiol Immunol Infect. 2020 May 15. doi: 10.1016/j.jmii.2020.05.001.spa
dc.relation.referencesAl-Sadeq DW, Nasrallah GK. The incidence of the novel coronavirus SARS-CoV-2 among asymptomatic patients: a systematic review. Int J Infect Dis. 2020 Jul 2:S1201-9712(20)30533-6. doi: 10.1016/j.ijid.2020.06.098.spa
dc.relation.referencesKronbichler A, Kresse D, Yoon S, Lee KH, Effenberger M, Shin JI. Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis. Int J Infect Dis. 2020 Jun 17:S1201-9712(20)30487-2. doi: 10.1016/j.ijid.2020.06.052.spa
dc.relation.referencesInstituto Nacional de Salud [en línea]. Colombia: 2020 [actualizada 11/07/2020]. Instructivo para la vigilancia en salud pública intensificada de infección respiratoria aguda asociada al nuevo coronavirus 2019 (COVID-19). Disponible en: https://www.ins.gov.co/Noticias/Coronavirus/Anexo_%20Instructivo%20Vigilancia%20COVID%20v11%2012052020.pdfspa
dc.relation.referencesOrganización Panamericana de la Salud, Organización Mundial de la Salud. Módulos de principios de epidemiología para el control de enfermedades (MOPECE). 2da edición revisada. Washington DC: OPS; 2002, 36 p. Disponible en: https://www.paho.org/bra/index.php?option=com_D.O.Cman&view=download&alias=1269-modulos-principios-epidemiologia-para-control-enfermedades-mopece-unidad-1-presentacion-marco-conceptual-9&category_slug=informacao-e-analise-saude-096&Itemid=965spa
dc.relation.referencesTostmann A, Bradley J, Bousema T, Yiek WK, Holwerda M, Bleeker-Rovers C, et al. Strong associations and moderate predictive value of early symptoms for SARS-CoV-2 test positivity among healthcare workers, the Netherlands, March 2020. Euro Surveill. 2020 Apr;25(16):2000508. https://doi.org/10.2807/1560-7917.ES.2020.25.16.2000508.spa
dc.relation.referencesStruyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MM, et al; Cochrane COVID-19 Diagnostic Test Accuracy Group. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. Cochrane Database Syst Rev. 2020 Jul 7;7:CD013665. https://doi.org/10.1002/14651858.CD013665.spa
dc.relation.referencesLovato A, de Filippis C. Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms. Ear Nose Throat J. 2020 Apr 13:145561320920762. https://doi.org/10.1177/0145561320920762.spa
dc.relation.referencesWynants Laure, Van Calster Ben, Collins Gary S, Riley Richard D, Heinze Georg, Schuit Ewoud et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ. 2020;369:m1328spa
dc.relation.referencesChung HS, Lee DE, Kim JK, Yeo IH, Kim C, Park J, et al. Revised Triage and Surveillance Protocols for Temporary Emergency Department Closures in Tertiary Hospitals as a Response to COVID-19 Crisis in Daegu Metropolitan City. J Korean Med Sci. 2020 May 18;35(19):e189. https://doi.org/10.3346/jkms.2020.35.e189.spa
dc.relation.referencesCenter for Disease Control and Prevention[online]. Unitted States of America: 2020. Standard Operating Procedure (SOP) for Triage of Suspected COVID-19 Patients in non-US Healthcare Settings: Early Identification and Prevention of Transmission during Triage. Available in: https://www.cdc.gov/coronavirus/2019-ncov/hcp/non-us-settings/sop-triage-prevent-transmission.html.spa
dc.relation.referencesShi Y, Wang X, Liu G, Zhu Q, Wang J, Yu H, et al. A quickly, effectively screening process of novel corona virus disease 2019 (COVID-19) in children in Shanghai, China. Ann Transl Med. 2020 Mar;8(5):241. https://doi.org/10.21037/atm.2020.03.22spa
dc.relation.referencesMinisterio de Salud y Protección Social [en línea]. Colombia: 2020. Colombia aumenta su capacidad hospitalaria para atención de covid-19. Disponible en: https://www.minsalud.gov.co/Paginas/Colombia-aumenta-su-capacidad-hospitalaria-para--atencion-de-covid-19.aspxspa
dc.relation.referencesCenter for Disease Control and Prevention[online]. Unitted States of America: 2020[Last Updated May 13, 2020]. Symptoms of Coronavirus. Available in: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.htmlspa
dc.rightsAníbal A. Teherán - 2020spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.sourcehttps://revistas.juanncorpas.edu.co/index.php/cuarzo/article/view/500spa
dc.subjectCoronaviruseng
dc.subjectCOVID-19eng
dc.subjectoperating capacitieseng
dc.subjectscreeningeng
dc.subjectoperational case definitioneng
dc.subjectCoronavirusspa
dc.subjectCOVID-19spa
dc.subjectcapacidades operativasspa
dc.subjecttamizajespa
dc.subjectdefinición operativa de casospa
dc.titleCapacidades operativas de las definiciones de caso de COVID-19, para detectar pacientes diagnosticados por RT-PCR.spa
dc.title.translatedOperational capabilities of the COVID-19 case definitions to detect patients diagnosed by RT-PCR.eng
dc.typeArtículo de revistaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.localJournal articleeng
dc.type.redcolhttp://purl.org/redcol/resource_type/ARTREFspa
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dspace.entity.typePublicationspa

Archivos